Cargando…

Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section

INTRODUCTION: The optimal surgical treatment for giant pituitary neuroendocrine tumors(GPitNETs) is debated. RESEARCH QUESTION: The aim of this paper is to optimize the surgical management of these patients and to provide a consensus statement on behalf of the EANS Skull Base Section. MATERIAL AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cossu, Giulia, Jouanneau, Emmanuel, Cavallo, Luigi M., Froelich, Sebastien, Starnoni, Daniele, Giammattei, Lorenzo, Harel, Ethan, Mazzatenta, Diego, Bruneau, Micheal, Meling, Torstein R., Berhouma, Moncef, Chacko, Ari G., Cornelius, Jan F., Paraskevopoulos, Dimitrios, Schroeder, Henry W.S., Zazpe, Idoya, Manet, Romain, Gardner, Paul A., Dufour, Henry, Cappabianca, Paolo, Daniel, Roy T., Messerer, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560664/
https://www.ncbi.nlm.nih.gov/pubmed/36248137
http://dx.doi.org/10.1016/j.bas.2022.100878
_version_ 1784807802517061632
author Cossu, Giulia
Jouanneau, Emmanuel
Cavallo, Luigi M.
Froelich, Sebastien
Starnoni, Daniele
Giammattei, Lorenzo
Harel, Ethan
Mazzatenta, Diego
Bruneau, Micheal
Meling, Torstein R.
Berhouma, Moncef
Chacko, Ari G.
Cornelius, Jan F.
Paraskevopoulos, Dimitrios
Schroeder, Henry W.S.
Zazpe, Idoya
Manet, Romain
Gardner, Paul A.
Dufour, Henry
Cappabianca, Paolo
Daniel, Roy T.
Messerer, Mahmoud
author_facet Cossu, Giulia
Jouanneau, Emmanuel
Cavallo, Luigi M.
Froelich, Sebastien
Starnoni, Daniele
Giammattei, Lorenzo
Harel, Ethan
Mazzatenta, Diego
Bruneau, Micheal
Meling, Torstein R.
Berhouma, Moncef
Chacko, Ari G.
Cornelius, Jan F.
Paraskevopoulos, Dimitrios
Schroeder, Henry W.S.
Zazpe, Idoya
Manet, Romain
Gardner, Paul A.
Dufour, Henry
Cappabianca, Paolo
Daniel, Roy T.
Messerer, Mahmoud
author_sort Cossu, Giulia
collection PubMed
description INTRODUCTION: The optimal surgical treatment for giant pituitary neuroendocrine tumors(GPitNETs) is debated. RESEARCH QUESTION: The aim of this paper is to optimize the surgical management of these patients and to provide a consensus statement on behalf of the EANS Skull Base Section. MATERIAL AND METHODS: We constituted a task force belonging to the EANS skull base committee to define some principles for the management of GPitNETs. A systematic review was performed according to PRISMA guidelines to perform a meta-analysis on surgical series of GPitNETs. Weighted summary rates were obtained for the pooled extent of resection and according to the surgical technique. These data were discussed to obtain recommendations after evaluation of the selected articles and discussion among the experts. RESULTS: 20articles were included in our meta-analysis, for a total of 1263 patients. The endoscopic endonasal technique was used in 40.3% of cases, the microscopic endonasal approach in 34% of cases, transcranial approaches in 18.7% and combined approaches in 7% of cases. No difference in terms of gross total resection (GTR) rate was observed among the different techniques. Pooled GTR rate was 36.6%, while a near total resection (NTR) was possible in 45.2% of cases. Cavernous sinus invasion was associated with a lower GTR rate (OR: 0.061). After surgery, 35% of patients had endocrinological improvement and 75.6% had visual improvement. Recurrent tumors were reported in 10% of cases DISCUSSION AND CONCLUSION: After formal discussion in the working group, we recommend the treatment of G-PitNETs tumors with a more complex and multilobular structure in tertiary care centers. The endoscopic endonasal approach is the first option of treatment and extended approaches should be planned according to extension, morphology and consistency of the lesion. Transcranial approaches play a role in selected cases, with a multicompartmental morphology, subarachnoid invasion and extension lateral to the internal carotid artery and in the management of residual tumor apoplexy.
format Online
Article
Text
id pubmed-9560664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95606642022-10-14 Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section Cossu, Giulia Jouanneau, Emmanuel Cavallo, Luigi M. Froelich, Sebastien Starnoni, Daniele Giammattei, Lorenzo Harel, Ethan Mazzatenta, Diego Bruneau, Micheal Meling, Torstein R. Berhouma, Moncef Chacko, Ari G. Cornelius, Jan F. Paraskevopoulos, Dimitrios Schroeder, Henry W.S. Zazpe, Idoya Manet, Romain Gardner, Paul A. Dufour, Henry Cappabianca, Paolo Daniel, Roy T. Messerer, Mahmoud Brain Spine Guideline INTRODUCTION: The optimal surgical treatment for giant pituitary neuroendocrine tumors(GPitNETs) is debated. RESEARCH QUESTION: The aim of this paper is to optimize the surgical management of these patients and to provide a consensus statement on behalf of the EANS Skull Base Section. MATERIAL AND METHODS: We constituted a task force belonging to the EANS skull base committee to define some principles for the management of GPitNETs. A systematic review was performed according to PRISMA guidelines to perform a meta-analysis on surgical series of GPitNETs. Weighted summary rates were obtained for the pooled extent of resection and according to the surgical technique. These data were discussed to obtain recommendations after evaluation of the selected articles and discussion among the experts. RESULTS: 20articles were included in our meta-analysis, for a total of 1263 patients. The endoscopic endonasal technique was used in 40.3% of cases, the microscopic endonasal approach in 34% of cases, transcranial approaches in 18.7% and combined approaches in 7% of cases. No difference in terms of gross total resection (GTR) rate was observed among the different techniques. Pooled GTR rate was 36.6%, while a near total resection (NTR) was possible in 45.2% of cases. Cavernous sinus invasion was associated with a lower GTR rate (OR: 0.061). After surgery, 35% of patients had endocrinological improvement and 75.6% had visual improvement. Recurrent tumors were reported in 10% of cases DISCUSSION AND CONCLUSION: After formal discussion in the working group, we recommend the treatment of G-PitNETs tumors with a more complex and multilobular structure in tertiary care centers. The endoscopic endonasal approach is the first option of treatment and extended approaches should be planned according to extension, morphology and consistency of the lesion. Transcranial approaches play a role in selected cases, with a multicompartmental morphology, subarachnoid invasion and extension lateral to the internal carotid artery and in the management of residual tumor apoplexy. Elsevier 2022-03-28 /pmc/articles/PMC9560664/ /pubmed/36248137 http://dx.doi.org/10.1016/j.bas.2022.100878 Text en Crown Copyright © 2022 Published by Elsevier B.V. on behalf of EUROSPINE, the Spine Society of Europe, EANS, the European Association of Neurosurgical Societies. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Guideline
Cossu, Giulia
Jouanneau, Emmanuel
Cavallo, Luigi M.
Froelich, Sebastien
Starnoni, Daniele
Giammattei, Lorenzo
Harel, Ethan
Mazzatenta, Diego
Bruneau, Micheal
Meling, Torstein R.
Berhouma, Moncef
Chacko, Ari G.
Cornelius, Jan F.
Paraskevopoulos, Dimitrios
Schroeder, Henry W.S.
Zazpe, Idoya
Manet, Romain
Gardner, Paul A.
Dufour, Henry
Cappabianca, Paolo
Daniel, Roy T.
Messerer, Mahmoud
Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title_full Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title_fullStr Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title_full_unstemmed Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title_short Surgical management of giant pituitary neuroendocrine tumors: Meta-analysis and consensus statement on behalf of the EANS skull base section
title_sort surgical management of giant pituitary neuroendocrine tumors: meta-analysis and consensus statement on behalf of the eans skull base section
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560664/
https://www.ncbi.nlm.nih.gov/pubmed/36248137
http://dx.doi.org/10.1016/j.bas.2022.100878
work_keys_str_mv AT cossugiulia surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT jouanneauemmanuel surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT cavalloluigim surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT froelichsebastien surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT starnonidaniele surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT giammatteilorenzo surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT harelethan surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT mazzatentadiego surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT bruneaumicheal surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT melingtorsteinr surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT berhoumamoncef surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT chackoarig surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT corneliusjanf surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT paraskevopoulosdimitrios surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT schroederhenryws surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT zazpeidoya surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT manetromain surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT gardnerpaula surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT dufourhenry surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT cappabiancapaolo surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT danielroyt surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection
AT messerermahmoud surgicalmanagementofgiantpituitaryneuroendocrinetumorsmetaanalysisandconsensusstatementonbehalfoftheeansskullbasesection